Key Takeaways
  • Research semaglutide is no longer available from verified suppliers (delisted at CertaPeptides since mid-2026, out of stock at AuraVia Research, never listed at SwissChems or AminoClub): no verified purchase option remains
  • Semaglutide is a GLP-1 receptor agonist studied for weight management and metabolism
  • Available, verified GLP-1 alternative: retatrutide (triple GIP/GLP-1/glucagon agonist) at AuraVia Research in Europe, as a vial (10 mg at EUR99) or a pre-filled pen (15 mg at EUR199.99), CoA for every batch
  • Strictly for research purposes only — not for human consumption

Our Recommendation

Research semaglutide is no longer offered by verified suppliers. After its delisting mid-2026 at CertaPeptides, no verified supplier (CertaPeptides, SwissChems, AminoClub) offers it (AuraVia Research lists it, but it is out of stock). There is therefore no verified purchase option for research semaglutide.

The only GLP-1 peptide still available at our verified European supplier is retatrutide, a triple agonist of the GIP / GLP-1 / glucagon receptors. We present it as the available, verified GLP-1 research alternative.

RegionSupplierAvailable GLP-1 ProductPriceShippingAction
EU Europe (incl. UK, CH, NO)AuraVia ResearchRetatrutide 10 mg (vial) or pre-filled penvial from EUR99, pen from EUR199.993-5 business days (EU)Order Retatrutide
Alternative (EU, UK, CH)CertaPeptidesRetatrutidesee site3-7 daysView at CertaPeptides
SemaglutideDelisted — no longer offered by any verified supplier since mid-2026

Important: Retatrutide is a compound strictly for research, not intended for human consumption. Pharmaceutical versions of semaglutide (Ozempic, Wegovy, Rybelsus) are available by prescription only.

GLP-1: Semaglutide vs Tirzepatide vs RetatrutideEnglish, subtitles FR · ES · DE · IT · PT

AuraVia Research: Retatrutide, the Verified GLP-1 Alternative

AuraVia Research is a European research-peptide supplier that ships from a warehouse in the EU. Semaglutide appears in its catalog, but it is out of stock. The GLP-1 peptide available at this verified supplier is retatrutide, a triple agonist of the GIP / GLP-1 / glucagon receptors, offered as a lyophilized vial and as a pre-filled pen.

Strengths

  • EU warehouse: ships across Europe, including the UK, Switzerland and Norway; standard tracked shipping in 3-5 business days within the EU
  • Shipping cost: EUR9, free from EUR150 (EU addresses; for the UK, Switzerland and Norway, the cost is shown at checkout)
  • Prices in EUR: VAT included
  • HPLC purity ≥99%: certificate of analysis (CoA) for every batch
  • Two formats: lyophilized vial or ready-to-use pre-filled pen, no reconstitution

Considerations

  • Outside the EU (UK, Switzerland, Norway), customs or import duties may apply
  • Semaglutide and tirzepatide are listed, but out of stock

Available Retatrutide

ProductDosagePriceLink
Retatrutide (lyophilized vial)10 mg / 20 mgEUR99 / EUR159Order Retatrutide
Retatrutide (pre-filled pen)15 mg / 40 mgEUR199.99 / EUR349.99View the Pre-filled Pen

The pre-filled pen is ready to use and needs no reconstitution. Our retatrutide pen article covers it in detail, and our vial or pre-filled pen guide compares the two formats. Retatrutide is a compound strictly for research, not intended for human consumption.

Alternative: CertaPeptides (EU, UK, Switzerland)

CertaPeptides, a supplier based in Romania, also offers retatrutide and ships to the EU, the UK and Switzerland: it is a European alternative to AuraVia Research. Shipping in 3-7 business days, 98%+ purity with HPLC and MS testing for each batch, independent CoA (Janoshik / Finnrick), credit card and crypto accepted, returns limited to 14 days. For other GLP-1/incretin compounds, browse its GLP-1 category.

Verified GLP-1 alternative for Europe: AuraVia Research offers retatrutide as a vial and as a pre-filled pen, with a CoA for every batch and shipping from the EU.

View Retatrutide at AuraVia Research

Semaglutide: Fully Delisted at Verified Suppliers

Since mid-2026, research semaglutide has been fully delisted at verified suppliers. CertaPeptides removed it from its catalog (its former product URLs now redirect to the category page), AuraVia Research lists it but it is out of stock, and neither SwissChems nor AminoClub ever listed it. No verified purchase option remains.

Why the Delisting?

  • Likely regulatory withdrawal: Semaglutide is a molecule commercialized in pharmaceutical form (Novo Nordisk: Ozempic, Wegovy, Rybelsus), which exposes its research version to increased scrutiny
  • Complex molecule: A 31 amino acid peptide with a specific lipid modification, expensive to synthesize
  • High demand: The popularity of Ozempic/Wegovy treatments has created regulatory pressure

Availability at Verified Suppliers

SupplierSemaglutideAvailable GLP-1 Alternative
AuraVia Research (Europe incl. UK, CH, NO)Listed, out of stockRetatrutide (vial and pre-filled pen)
CertaPeptides (EU, UK, Switzerland)Delisted (mid-2026)Retatrutide (triple GIP/GLP-1/glucagon agonist)
SwissChemsNot availableNot available
AminoClubNot availableNot available

The only GLP-1 peptide still available at a verified supplier is retatrutide, offered in Europe by AuraVia Research (CertaPeptides remains a European alternative).

GLP-1 alternative for Europe: retatrutide at AuraVia Research (vial from EUR99), also as a pre-filled pen, CoA for every batch.

About Semaglutide

Semaglutide is a synthetic peptide in the class of GLP-1 receptor agonists (glucagon-like peptide-1). It is the subject of intensive research in several fields:

Research Areas

  • Weight management: STEP clinical trials showed significant results in obesity research
  • Glucose metabolism: Study of mechanism of action on glucose-dependent insulin secretion
  • Cardiovascular health: SELECT trial studied effects on cardiovascular events
  • Neuroprotection: Emerging research on potential effects on the central nervous system

Molecular Characteristics

PropertyValue
Molecular formulaC187H291N45O59
Molecular weight4113.58 g/mol
Half-life~7 days (prolonged by albumin binding)
TypeGLP-1 receptor agonist

For more information on mechanism of action and clinical studies, see our complete semaglutide guide.

How to Verify Quality

Since semaglutide is a complex and expensive molecule, it is essential to verify supplier quality:

1. Certificate of Analysis (CoA)

A serious supplier provides a batch-specific CoA. This document should include:

  • HPLC chromatogram showing purity (98%+ minimum)
  • Mass spectrometry (MS) confirming exact molecular weight (4113.58 g/mol)
  • Endotoxin testing
  • Batch number matching the label

2. Storage and Shipping

Semaglutide is temperature sensitive:

  • Optimal storage at -20C
  • Shipping with ice packs or dry ice
  • Insulated packaging required

3. Reference Pricing

Quality research semaglutide costs between EUR25 and EUR60 for 5mg. A significantly lower price is a warning sign.

4. Red Flags to Avoid

  • No CoA available
  • Abnormally low prices (
  • Sellers without verifiable history
  • Sites without clear legal information

Verified GLP-1 alternative (semaglutide is no longer listed):

Semaglutide Buying FAQ

Frequently Asked Questions

Is it legal to buy semaglutide for research?
In practice, the question is now moot: since mid-2026, research semaglutide is no longer offered by verified suppliers (delisting, likely regulatory withdrawal). Even where buying it for research remained legal, no verified purchase option exists. These products are in any case strictly for laboratory research, not intended for human consumption. Pharmaceutical versions (Ozempic, Wegovy) require a medical prescription.
Why is semaglutide so hard to find?
Semaglutide is a complex 31 amino acid molecule with a lipid modification. Its synthesis is expensive and technically difficult, limiting the number of suppliers capable of producing it with sufficient purity.
What is the difference between research semaglutide and Ozempic/Wegovy?
Research semaglutide is the raw molecule in lyophilized form, intended for laboratories. Ozempic and Wegovy are pharmaceutical formulations approved by health authorities, with precise dosing and injection devices, available by prescription only.
How should I store semaglutide after receiving it?
Powder (lyophilized) form: freezer at -20C, protected from light. Shelf life: 1-2 years. After reconstitution: refrigerator (2-8C), use within 2-4 weeks. Never refreeze a reconstituted solution.
Can I buy semaglutide in the USA?
No. Since its delisting mid-2026, no verified research supplier offers semaglutide, in the USA or anywhere else. American buyers have no verified research option; the pharmaceutical versions (Ozempic, Wegovy) remain available by prescription only.
Where to buy semaglutide in Europe?
Research semaglutide has no longer been listed by verified suppliers since mid-2026, so there is no verified purchase option anymore. The only GLP-1 peptide still available at our verified European supplier is retatrutide (triple GIP/GLP-1/glucagon agonist): AuraVia Research, EU warehouse, 3-5 business day delivery, as a vial (10 mg at EUR99) or a pre-filled pen (15 mg at EUR199.99), certificate of analysis for every batch. AuraVia also ships to the UK, Switzerland and Norway, and CertaPeptides remains a European alternative. A compound strictly for research.
Is there a CertaPeptides discount code?
Yes. Our partner code AFF-KLOWPEPTIDE gives 10% off your first order at CertaPeptides. It is not applied automatically: enter it in the coupon field of your cart. When you click a CertaPeptides link on our site, the code is copied for you.
Does AuraVia Research have a discount code?
You do not need a code. Through our links, AuraVia Research gives 10% off your first order: the discount is applied automatically in the cart.

Recommended products

Research peptides selected for quality and purity:

Pen · Europe
Retatrutide Pen

Retatrutide Pen

Pre-filled Pen Retatrutide

Pack · Europe
Transform DUO

Transform DUO

2-pen pack: Retatrutide, Glow

New
Retatrutide

Retatrutide

Metabolic Peptide

Test your knowledge

Quick quiz · 6 questions

Sources

  1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med, 384(11), 989-1002. (PubMed)
  2. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med, 389(24), 2221-2232. (PubMed)
  3. Marso SP, Bain SC, Consoli A, et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). N Engl J Med, 375(19), 1834-1844. (PubMed)

This content is for informational and educational purposes only. It does not constitute medical advice. Consult a healthcare professional before making any decisions. Read our full medical disclaimer